Panot Sainamthip

Panot Sainamthip

Chulalongkorn University - Bangkok / Thailand
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 5824014
จุฬาลงกรณ์มหาวิทยาลัย
person_outline Panot Sainamthip's MOST POPULAR ARTICLES
1-) The effect of intravenous mannitol combined with normal saline in preventing cisplatin-induced nephrotoxicity: a randomized, double-blind, placebo-controlled trialP Sainamthip, S Saichaemchan, B Satirapoj, N PrasongsookJCO Global Oncology 8, e2100275, 2022122022
2-) Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: a prospective, multicenter observational studyN Teeyapun, S Luangdilok, N Pakvisal, P Sainamthip, S Mingmalairak, ...EClinicalMedicine 52, 202282022
3-) Immunogenicity after a third COVID-19 mRNA booster in solid cancer patients who previously received the primary heterologous CoronaVac/ChAdOx1 vaccineS Luangdilok, P Wanchaijiraboon, N Pakvisal, T Susiriwatananont, ...Vaccines 10 (10), 1613, 202282022
4-) Vaccine-Related adverse events following AZD1222 (ChAdOx1-nCoV-19) Covid-19 vaccine in solid malignancy patients receiving cancer treatment, as compared to age-matched healthy …N Pakvisal, P Sainamthip, N Teeyapun, S Luangdilok, N Wanlapakorn, ...Human Vaccines & Immunotherapeutics 18 (6), 2094149, 202262022
5-) Single dose dexamethasone prophylaxis of postembolisation syndrome after chemoembolisation in hepatocellular carcinoma patient: a randomised, double-blind, placebo-controlled studyP Sainamthip, C Kongphanich, N Prasongsook, S ChirapongsathornWorld Journal of Clinical Cases 9 (30), 9059, 202162021